Relay Therapeutics, Inc.RLAYNASDAQ
Loading
Operating cash flow minus capital expenditures
Latest
$-235.87M
↓ 42% vs avg
Percentile
P43
Within normal range
Streak
2 yr
Consecutive growthContracting
Average
$-166.53M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $-235.87M | +6.1% |
| 2024 | $-251.13M | +17.5% |
| 2023 | $-304.44M | -27.6% |
| 2022 | $-238.55M | -206.3% |
| 2021 | $-77.88M | +25.4% |
| 2020 | $-104.42M | -40.9% |
| 2019 | $-74.14M | -61.8% |
| 2018 | $-45.82M | - |